• 2332 Citations
  • 25 h-Index
1996 …2022
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Area of Expertise

Dr. Basha's research expertise is in the field of experimental therapeutics and cancer. His research focuses on examining aberrant expression of molecular markers associated with aggressive disease and poor prognosis for a variety of human malignancies.
Ongoing research focuses on testing the combination of novel investigational agents with other standard therapeutic options (chemotherapy and/or radiation), and understanding the potential molecular pathways associated with proposed combinations. Novel therapeutic strategies involving small molecules, herbal products, and their analogs are under testing through rigorous pre-clinical screening using models for leukemia, pancreatic, ovarian, prostate, and central nervous system cancers.

Education/Academic qualification

PhD in Neurobiology, Sri Venkateswara University

MS in Molecular Physiology, Sri Venkateswara University

BS in Biology and Chemistry, Sri Venkateswara University

Fingerprint Dive into the research topics where Riyaz Basha is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Neoplasms Medicine & Life Sciences
Sp Transcription Factors Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Alzheimer Disease Medicine & Life Sciences
Sp1 Transcription Factor Medicine & Life Sciences
Amyloid beta-Protein Precursor Medicine & Life Sciences
Growth Medicine & Life Sciences
Proteins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2022

Research Output 1996 2019

1 Citation (Scopus)
Open Access
Health
Aptitude
Translational Medical Research
Organized Financing
Self Efficacy
1 Citation (Scopus)

Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells

Shelake, S., Sankpal, U. T., Eslin, D., Bowman, P., Simecka, J., Raut, S. L., Ray, A. & Basha, R. M., 15 Feb 2019, In : Apoptosis. 24, 1-2, p. 21-32 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Ewing's Sarcoma
Vincristine
Cells
Caspase 7
Cell Survival

Combination of clotam and vincristine enhances anti-proliferative effect in medulloblastoma cells

Patil, S., Sankpal, U. T., Hurtado, M., Bowman, P., Murray, J., Borgmann, K., Ghorpade, A., Sutphin, R., Eslin, D. & Basha, R. M., 15 Jul 2019, In : Gene. 705, p. 67-76 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Medulloblastoma
Vincristine
tolfenamic acid
Cell Cycle
Apoptosis
1 Citation (Scopus)

Copper-tolfenamic acid: evaluation of stability and anti-cancer activity

Hurtado, M., Sankpal, U. T., Chhabra, J., Brown, D. T., Maram, R., Patel, R., Gurung, R. K., Simecka, J., Holder, A. A. & Basha, R. M., 15 Feb 2019, In : Investigational New Drugs. 37, 1, p. 27-34 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Copper
Neoplasms
Powders
tolfenamic acid
Cell Line

Evidence-based approaches to reduce cancer health disparities: Discover, develop, deliver, and disseminate

Desai, P. P., Lampe, J. B., Bakre, S. A., Basha, R. M., Jones, H. & Vishwanatha, J. K., 1 Jan 2018, In : Journal of Carcinogenesis. 17, 1, 17.

Research output: Contribution to journalArticleResearchpeer-review

Health
Neoplasms
Prostatic Neoplasms
Public Health
Minority Health